The impact of perennial malaria chemoprevention on key health outcomes in children aged 2–18 months: Results from a cluster-randomised controlled trial in Nigeria
Published:
Resources: Presentation
Authors: Olusola Oresanya
Perennial malaria chemoprevention is associated with reductions in all-cause consultations, cases of clinical malaria and cases of severe malaria; improved coverage is expected to lead to greater impact.
The Perennial Malaria Chemoprevention (PMC) Effect Study is a type 2 hybrid effectiveness-implementation study delivering sulfadoxine-pyrimethamine (SP) in the first and second years of life in Nigeria. It aims to catalyse decision-making in Nigeria regarding policy adoption of PMC.
This presentation was given at the 2025 Annual Meeting of the American Society of Tropical Medicine and Hygiene, held on 9-13 November in Toronto, Canada.
Tagged under:
Conference
American Society of Tropical Medicine and Hygiene Annual Meeting